<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">19002158</PMID>
      <DateCompleted>
        <Year>2009</Year>
        <Month>02</Month>
        <Day>10</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>10</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1748-7838</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>19</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2009</Year>
              <Month>Jan</Month>
            </PubDate>
          </JournalIssue>
          <Title>Cell research</Title>
          <ISOAbbreviation>Cell Res</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Signaling cross-talk between TGF-beta/BMP and other pathways.</ArticleTitle>
        <Pagination>
          <StartPage>71</StartPage>
          <EndPage>88</EndPage>
          <MedlinePgn>71-88</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1038/cr.2008.302</ELocationID>
        <Abstract>
          <AbstractText>Transforming growth factor-beta (TGF-beta)/bone morphogenic protein (BMP) signaling is involved in the vast majority of cellular processes and is fundamentally important during the entire life of all metazoans. Deregulation of TGF-beta/BMP activity almost invariably leads to developmental defects and/or diseases, including cancer. The proper functioning of the TGF-beta/BMP pathway depends on its constitutive and extensive communication with other signaling pathways, leading to synergistic or antagonistic effects and eventually desirable biological outcomes. The nature of such signaling cross-talk is overwhelmingly complex and highly context-dependent. Here we review the different modes of cross-talk between TGF-beta/BMP and the signaling pathways of Mitogen-activated protein kinase, phosphatidylinositol-3 kinase/Akt, Wnt, Hedgehog, Notch, and the interleukin/interferon-gamma/tumor necrosis factor-alpha cytokines, with an emphasis on the underlying molecular mechanisms.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Guo</LastName>
            <ForeName>Xing</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC 27710, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Xiao-Fan</ForeName>
            <Initials>XF</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>R01 DK064113</GrantID>
            <Acronym>DK</Acronym>
            <Agency>NIDDK NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01 GM083000</GrantID>
            <Acronym>GM</Acronym>
            <Agency>NIGMS NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>DK064113</GrantID>
            <Acronym>DK</Acronym>
            <Agency>NIDDK NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>GM083000</GrantID>
            <Acronym>GM</Acronym>
            <Agency>NIGMS NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Cell Res</MedlineTA>
        <NlmUniqueID>9425763</NlmUniqueID>
        <ISSNLinking>1001-0602</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D019485">Bone Morphogenetic Proteins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D036341">Intercellular Signaling Peptides and Proteins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D018125">Receptors, Transforming Growth Factor beta</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D014157">Transcription Factors</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D016212">Transforming Growth Factor beta</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D019485" MajorTopicYN="N">Bone Morphogenetic Proteins</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D036341" MajorTopicYN="N">Intercellular Signaling Peptides and Proteins</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D020935" MajorTopicYN="N">MAP Kinase Signaling System</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D020239" MajorTopicYN="Y">Receptor Cross-Talk</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018125" MajorTopicYN="N">Receptors, Transforming Growth Factor beta</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015398" MajorTopicYN="Y">Signal Transduction</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014157" MajorTopicYN="N">Transcription Factors</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016212" MajorTopicYN="N">Transforming Growth Factor beta</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2008</Year>
          <Month>11</Month>
          <Day>13</Day>
          <Hour>9</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2009</Year>
          <Month>2</Month>
          <Day>12</Day>
          <Hour>9</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2008</Year>
          <Month>11</Month>
          <Day>13</Day>
          <Hour>9</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">19002158</ArticleId>
        <ArticleId IdType="mid">NIHMS451002</ArticleId>
        <ArticleId IdType="pmc">PMC3606489</ArticleId>
        <ArticleId IdType="doi">10.1038/cr.2008.302</ArticleId>
        <ArticleId IdType="pii">cr2008302</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Massagué J. How cells read TGF-beta signals. Nat Rev Mol Cell Biol. 2000;1:169–178.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11252892</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gomis RR, Alarcon C, Nadal C, Van Poznak C, Massague J. C/EBPbeta at the core of the TGFbeta cytostatic response and its evasion in metastatic breast cancer cells. Cancer Cell. 2006;10:203–214.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16959612</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shi Y, Massagué J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell. 2003;113:685–700.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12809600</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bierie B, Moses HL. Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer. Nat Rev Cancer. 2006;6:506–520.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16794634</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Massagué J, Blain SW, Lo RS. TGFβ signaling in growth control, cancer, and heritable disorders. Cell. 2000;103:295–309.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11057902</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Siegel PM, Shu W, Cardiff RD, Muller WJ, Massagué J. Transforming growth factor β signaling impairs Neu-induced mammary tumorigenesis while promoting pulmonary metastasis. Proc Natl Acad Sci USA. 2003;100:8430–8435.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC166246</ArticleId>
            <ArticleId IdType="pubmed">12808151</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Massagué J. TGF[beta] in cancer. Cell. 2008;134:215–230.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3512574</ArticleId>
            <ArticleId IdType="pubmed">18662538</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li MO, Flavell RA. TGF-[beta]: a master of all T cell trades. Cell. 2008;134:392–404.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3677783</ArticleId>
            <ArticleId IdType="pubmed">18692464</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Heldin C-H, Miyazono K, Dijke Pt. TGF-β signalling from cell membrane to nucleus through SMAD proteins. Nature. 1997;390:465.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9393997</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sporn MB. The early history of TGF-beta, and a brief glimpse of its future. Cytokine Growth Factor Rev. 2006;17:3–7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16290110</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Anzano MA, Roberts AB, Meyers CA, et al.  Communication: synergistic interaction of two classes of transforming growth factors from murine sarcoma cells. Cancer Res. 1982;42:4776–4778.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6290046</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Roberts AB, Anzano MA, Lamb LC, Smith JM, Sporn MB. New class of transforming growth factors potentiated by epidermal growth factor: isolation from non-neoplastic tissues. Proc Natl Acad Sci USA. 1981;78:5339–5343.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC348740</ArticleId>
            <ArticleId IdType="pubmed">6975480</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Roberts AB, Lamb LC, Newton DL, Sporn MB, De Larco JE, To-daro GJ. Transforming growth factors: isolation of polypeptides from virally and chemically transformed cells by acid/ethanol extraction. Proc Natl Acad Sci USA. 1980;77:3494–3498.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC349643</ArticleId>
            <ArticleId IdType="pubmed">6251462</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Smith JM, Sporn MB, Roberts AB, Derynck R, Winkler ME, Gregory H. Human transforming growth factor-[alpha] causes precocious eyelid opening in newborn mice. Nature. 1985;315:515–516.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3873618</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mishra L, Shetty K, Tang Y, Stuart A, Byers SW. The role of TGF-beta and Wnt signaling in gastrointestinal stem cells and cancer. Oncogene. 2005;24:5775–5789.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16123810</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pires-daSilva A, Sommer RJ. The evolution of signalling pathways in animal development. Nat Rev Genet. 2003;4:39–49.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12509752</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Attisano L, Labbe E. TGFbeta and Wnt pathway cross-talk. Cancer Metastasis Rev. 2004;23:53–61.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15000149</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gerhart J. 1998 Warkany lecture: signaling pathways in development. Teratology. 1999;60:226–239.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10508976</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sumi T, Tsuneyoshi N, Nakatsuji N, Suemori H. Defining early lineage specification of human embryonic stem cells by the orchestrated balance of canonical Wnt/{beta}-catenin, Ac-tivin/Nodal and BMP signaling. Development. 2008;135:2969–2979.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18667462</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rao M. Conserved and divergent paths that regulate self-renewal in mouse and human embryonic stem cells. Dev Biol. 2004;275:269–286.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15501218</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chang L, Karin M. Mammalian MAP kinase signalling cascades. Nature. 2001;410:37–40.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11242034</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Karnoub AE, Weinberg RA. Ras oncogenes: split personalities. Nat Rev Mol Cell Biol. 2008;9:517–531.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3915522</ArticleId>
            <ArticleId IdType="pubmed">18568040</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100:57–70.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10647931</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moustakas A, Heldin CH. Non-Smad TGF-beta signals. J Cell Sci. 2005;118:3573–3584.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16105881</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Derynck R, Zhang YE. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature. 2003;425:577–584.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14534577</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Muraoka RS, Koh Y, Roebuck LR, et al.  Increased malignancy of Neu-induced mammary tumors overexpressing active transforming growth factor {beta}1. Mol Cell Biol. 2003;23:8691–8703.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC262670</ArticleId>
            <ArticleId IdType="pubmed">14612410</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ueda Y, Wang S, Dumont N, Yi JY, Koh Y, Arteaga CL. Over-expression of HER2 (erbB2 in human breast epithelial cells unmasks transforming growth factor beta-induced cell motility. J Biol Chem. 2004;279:24505–24513.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15044465</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Janda E, Lehmann K, Killisch I, et al.  Ras and TGF[beta] cooperatively regulate epithelial cell plasticity and metastasis: dissection of Ras signaling pathways. J Cell Biol. 2002;156:299–313.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2199233</ArticleId>
            <ArticleId IdType="pubmed">11790801</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang SE, Xiang B, Guix M, et al.  Transforming growth factor {beta} engages TACE and ErbB3 to activate PI3K/Akt in ErbB2-overexpressing breast cancer and desensitizes cells to Trastuzumab. Mol Cell Biol. 2008;28:5605–5620.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2546920</ArticleId>
            <ArticleId IdType="pubmed">18625725</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Seton-Rogers SE, Brugge JS. ErbB2 and TGF-beta: a cooperative role in mammary tumor progression? Cell Cycle. 2004;3:597–600.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15107620</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Seton-Rogers SE, Lu Y, Hines LM, et al.  Cooperation of the ErbB2 receptor and transforming growth factor beta in induction of migration and invasion in mammary epithelial cells. Proc Natl Acad Sci USA. 2004;101:1257–1262.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC337040</ArticleId>
            <ArticleId IdType="pubmed">14739340</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lehmann K, Janda E, Pierreux CE, et al.  Raf induces TGF-beta production while blocking its apoptotic but not invasive responses: a mechanism leading to increased malignancy in epithelial cells. Genes Dev. 2000;14:2610–2622.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC316988</ArticleId>
            <ArticleId IdType="pubmed">11040215</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Oft M, Peli J, Rudaz C, Schwarz H, Beug H, Reichmann E. TGF-beta1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells. Genes Dev. 1996;10:2462–2477.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8843198</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yue J, Mulder KM. Requirement of Ras/MAPK pathway activation by transforming growth factor beta for transforming growth factor beta 1 production in a Smad-dependent pathway. J Biol Chem. 2000;275:30765–30773.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10843986</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ventura JJ, Kennedy NJ, Flavell RA, Davis RJ. JNK regulates autocrine expression of TGF-beta1. Mol Cell. 2004;15:269–278.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15260977</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ross KR, Corey DA, Dunn JM, Kelley TJ. SMAD3 expression is regulated by mitogen-activated protein kinase kinase-1 in epithelial and smooth muscle cells. Cell Signal. 2007;19:923–931.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17197157</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gotzmann J, Fischer ANM, Zojer M, et al.  A crucial function of PDGF in TGF-[beta]-mediated cancer progression of hepatocytes. Oncogene. 2006;25:3170–3185.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16607286</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bruna A, Darken RS, Rojo F, et al.  High TGFbeta-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B gene. Cancer Cell. 2007;11:147–160.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17292826</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kretzschmar M, Doody J, Timokhina I, Massague J. A mechanism of repression of TGFbeta/Smad signaling by oncogenic Ras. Genes Dev. 1999;13:804–816.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC316599</ArticleId>
            <ArticleId IdType="pubmed">10197981</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hu PP-c, Shen X, Huang D, Liu Y, Counter C, Wang XF. The MEK pathway is required for stimulation of p21WAF1/CIP1 by transforming growth factor-beta. J Biol Chem. 1999;274:35381–35387.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10585406</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dunfield LD, Nachtigal MW. Inhibition of the antiproliferative effect of TGFbeta by EGF in primary human ovarian cancer cells. Oncogene. 2003;22:4745–4751.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12879019</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>de Caestecker MP, Parks WT, Frank CJ, et al.  Smad2 transduces common signals from receptor serine-threonine and tyrosine kinases. Genes Dev. 1998;12:1587–1592.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC316877</ArticleId>
            <ArticleId IdType="pubmed">9620846</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brown JD, DiChiara MR, Anderson KR, Gimbrone MA, Jr, Topper JN. MEKK-1, a component of the stress (stress-activated protein kinase/c-Jun N-terminal kinase) pathway, can selectively activate Smad2-mediated transcriptional activation in endothelial cells. J Biol Chem. 1999;274:8797–8805.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10085121</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mori S, Matsuzaki K, Yoshida K, et al.  TGF-[beta] and HGF transmit the signals through JNK-dependent Smad2//3 phosphorylation at the linker regions. Oncogene. 2004;23:7416–7429.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15326485</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Matsuura I, Wang G, He D, Liu F. Identification and characterization of ERK MAP kinase phosphorylation sites in Smad3. Biochemistry. 2005;44:12546–12553.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16156666</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kamaraju AK, Roberts AB. Role of Rho/ROCK and p38 MAP kinase pathways in transforming growth factor-{beta}-mediated Smad-dependent growth inhibition of human breast carcinoma cells in vivo. J Biol Chem. 2005;280:1024–1036.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15520018</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guo X, Ramirez A, Waddell DS, Li Z, Liu X, Wang XF. Axin and GSK3-β control Smad3 protein stability and modulate TGF-β signaling. Genes Dev. 2008;22:106–120.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2151009</ArticleId>
            <ArticleId IdType="pubmed">18172167</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eivers E, Fuentealba LC, De Robertis EM. Integrating positional information at the level of Smad1/5/8. Curr Opin Genet Dev. 2008;18:304–310.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3033225</ArticleId>
            <ArticleId IdType="pubmed">18590818</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kretzschmar M, Doody J, Massagu J. Opposing BMP and EGF signalling pathways converge on the TGF-[beta] family mediator Smad1. Nature. 1997;389:618–622.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9335504</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sapkota G, Alarcon C, Spagnoli FM, Brivanlou AH, Massague J. Balancing BMP signaling through integrated inputs into the Smad1 linker. Mol Cell. 2007;25:441–454.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17289590</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kuroda H, Fuentealba L, Ikeda A, Reversade B, De Robertis EM. Default neural induction: neuralization of dissociated Xenopus cells is mediated by Ras/MAPK activation. Genes Dev. 2005;19:1022–1027.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1091736</ArticleId>
            <ArticleId IdType="pubmed">15879552</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bilican B, Fiore-Heriche C, Compston A, Allen ND, Chandran S. Induction of Olig2 precursors by FGF involves BMP signalling blockade at the Smad level. PLoS ONE. 2008;3:e2863.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2483937</ArticleId>
            <ArticleId IdType="pubmed">18682850</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fuentealba LC, Eivers E, Ikeda A, et al.  Integrating patterning signals: Wnt/GSK3 regulates the duration of the BMP/Smad1 signal. Cell. 2007;131:980–993.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2200633</ArticleId>
            <ArticleId IdType="pubmed">18045539</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wilson S, Rydstrom A, Trimborn T, et al.  The status of Wnt signalling regulates neural and epidermal fates in the chick embryo. Nature. 2001;411:325–330.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11357137</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Qiu T, Grizzle WE, Oelschlager DK, Shen X, Cao X. Control of prostate cell growth: BMP antagonizes androgen mitogenic activity with incorporation of MAPK signals in Smad1. EMBO J. 2007;26:346–357.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1783451</ArticleId>
            <ArticleId IdType="pubmed">17183365</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zeng YA, Rahnama M, Wang S, Sosu-Sedzorme W, Verheyen EM. Drosophila Nemo antagonizes BMP signaling by phosphorylation of Mad and inhibition of its nuclear accumulation. Development. 2007;134:2061–2071.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17507407</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Saha D, Datta PK, Beauchamp RD. Oncogenic Ras represses transforming growth factor-beta/Smad signaling by degrading tumor suppressor Smad4. J Biol Chem. 2001;276:29531–29537.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11371552</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liang M, Liang YY, Wrighton K, et al.  Ubiquitination and proteolysis of cancer-derived Smad4 mutants by SCFSkp2. Mol Cell Biol. 2004;24:7524–7537.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC506984</ArticleId>
            <ArticleId IdType="pubmed">15314162</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brodin G, Ahgren A, ten Dijke P, Heldin C-H, Heuchel R. Efficient TGF-beta induction of the Smad7 gene requires cooperation between AP-1, Sp1, and Smad proteins on the mouse Smad7 promoter. J Biol Chem. 2000;275:29023–29030.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10843994</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dowdy SC, Mariani A, Janknecht R. HER2/Neu- and TAK1-mediated up-regulation of the transforming growth factor {beta} inhibitor Smad7 via the ETS protein ER81. J Biol Chem. 2003;278:44377–44384.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12947087</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Uchida K, Suzuki H, Ohashi T, Nitta K, Yumura W, Nihei H. Involvement of MAP kinase cascades in Smad7 transcriptional regulation. Biochem Biophys Res Commun. 2001;289:376–381.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11716483</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yanai M, Tatsumi N, Hasunuma N, Katsu K, Endo F, Yokouchi Y. FGF signaling segregates biliary cell-lineage from chick hepatoblasts cooperatively with BMP4 and ECM components in vitro. Dev Dyn. 2008;237:1268–1283.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18393311</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yoon BS, Pogue R, Ovchinnikov DA, et al.  BMPs regulate multiple aspects of growth-plate chondrogenesis through opposing actions on FGF pathways. Development. 2006;133:4667–4678.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17065231</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Verheyden JM, Sun X. An Fgf/Gremlin inhibitory feedback loop triggers termination of limb bud outgrowth. Nature. 2008;454:638–641.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2840222</ArticleId>
            <ArticleId IdType="pubmed">18594511</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shaulian E, Karin M. AP-1 as a regulator of cell life and death. Nat Cell Biol. 2002;4:E131–E136.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11988758</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang Y, Feng XH, Derynck R. Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-[beta]-induced transcription. Nature. 1998;394:909–913.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9732876</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wong C, Rougier-Chapman EM, Frederick JP, et al.  Smad3-Smad4 and AP-1 complexes synergize in transcriptional activation of the c-Jun promoter by transforming growth factor beta. Mol Cell Biol. 1999;19:1821–1830.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC83975</ArticleId>
            <ArticleId IdType="pubmed">10022869</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yamamura Y, Hua X, Bergelson S, Lodish HF. Critical role of Smads and AP-1 complex in transforming growth factor-beta-dependent apoptosis. J Biol Chem. 2000;275:36295–36302.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10942775</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dennler S, Prunier C, Ferrand N, Gauthier JM, Atfi A. c-Jun inhibits transforming growth factor beta -mediated transcription by repressing Smad3 transcriptional activity. J Biol Chem. 2000;275:28858–28865.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10871633</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Attisano L, Wrana JL. Smads as transcriptional co-modulators. Curr Opin Cell Biol. 2000;12:235–243.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10712925</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Javelaud D, Mauviel A. Crosstalk mechanisms between the mitogen-activated protein kinase pathways and Smad signaling downstream of TGF-[beta]: implications for carcinogenesis. Oncogene. 2005;24:5742–5750.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16123807</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Verrecchia F, Vindevoghel L, Lechleider RJ, Uitto J, Roberts AB, Mauviel A. Smad3/AP-1 interactions control transcriptional responses to TGF-beta in a promoter-specific manner. Oncogene. 2001;20:3332–3340.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11423983</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Matsumura H, Kudo T, Harada A, et al.  Suppression of MafA-dependent transcription by transforming growth factor-beta signaling. Biochem Biophys Res Commun. 2007;364:151–156.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17927952</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hanafusa H, Ninomiya-Tsuji J, Masuyama N, et al.  Involvement of the p38 mitogen-activated protein kinase pathway in transforming growth factor-beta-induced gene expression. J Biol Chem. 1999;274:27161–27167.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10480932</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jin EJ, Lee SY, Choi YA, Jung JC, Bang OS, Kang SS. BMP-2-enhanced chondrogenesis involves p38 MAPK-mediated down-regulation of Wnt-7a pathway. Mol Cells. 2006;22:353–359.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17202865</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sano Y, Harada J, Tashiro S, Gotoh-Mandeville R, Maekawa T, Ishii S. ATF-2 is a common nuclear target of Smad and TAK1 pathways in transforming growth factor-beta signaling. J Biol Chem. 1999;274:8949–8957.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10085140</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thomas DA, Massagué J. TGF-[beta] directly targets cytotoxic T cell functions during tumor evasion of immune surveillance. Cancer Cell. 2005;8:369–380.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16286245</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Monzen K, Hiroi Y, Kudoh S, et al.  Smads, TAK1, and their common target ATF-2 play a critical role in cardiomyocyte differentiation. J Cell Biol. 2001;153:687–698.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2192375</ArticleId>
            <ArticleId IdType="pubmed">11352931</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Verrecchia F, Tacheau C, Schorpp-Kistner M, Angel P, Mauviel A. Induction of the AP-1 members c-Jun and JunB by TGF-beta/Smad suppresses early Smad-driven gene activation. Oncogene. 2001;20:2205–2211.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11402315</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jonk LJ, Itoh S, Heldin CH, ten Dijke P, Kruijer W. Identification and functional characterization of a Smad binding element (SBE) in the JunB promoter that acts as a transforming growth factor-beta, activin, and bone morphogenetic protein-inducible enhancer. J Biol Chem. 1998;273:21145–21152.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9694870</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kang Y, Chen CR, Massagué J. A self-enabling TGFβ response coupled to stress signaling: Smad engages stress response factor ATF3 for Id1 repression in epithelial cells. Mol Cell. 2003;11:915–926.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12718878</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cantley LC. The phosphoinositide 3-kinase pathway. Science. 2002;296:1655–1657.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12040186</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bader AG, Kang S, Zhao L, Vogt PK. Oncogenic PI3K deregulates transcription and translation. Nat Rev Cancer. 2005;5:921–999.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16341083</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Salmena L, Carracedo A, Pandolfi PP. Tenets of PTEN tumor suppression. Cell. 2008;133:403–14.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18455982</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen RH, Su YH, Chuang RL, Chang TY. Suppression of transforming growth factor-beta-induced apoptosis through a phosphatidylinositol 3-kinase/Akt-dependent pathway. Oncogene. 1998;17:1959–1968.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9788439</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen RH, Chang MC, Su YH, Tsai YT, Kuo ML. Interleukin-6 inhibits transforming growth factor-beta-induced apoptosis through the phosphatidylinositol 3-kinase/Akt and signal transducers and activators of transcription 3 pathways. J Biol Chem. 1999;274:23013–23019.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10438468</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fukuda M, Longnecker R. Latent membrane protein 2A inhibits transforming growth factor-{beta}1-induced apoptosis through the phosphatidylinositol 3-kinase/Akt pathway. J Virol. 2004;78:1697–1705.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC369507</ArticleId>
            <ArticleId IdType="pubmed">14747535</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shih WL, Kuo ML, Chuang SE, Cheng AL, Doong SL. Hepatitis B virus X protein inhibits transforming growth factor-beta-induced apoptosis through the activation of phosphatidylinositol 3-kinase pathway. J Biol Chem. 2000;275:25858–25864.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10835427</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Song K, Cornelius SC, Reiss M, Danielpour D. Insulin-like growth factor-I inhibits transcriptional responses of transforming growth factor-{beta} by phosphatidylinositol 3-kinase/Akt-dependent suppression of the activation of Smad3 but not Smad2. J Biol Chem. 2003;278:38342–38351.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12876289</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Asano Y, Ihn H, Yamane K, Jinnin M, Mimura Y, Tamaki K. Phosphatidylinositol 3-kinase is involved in {alpha}2(I) collagen gene expression in normal and scleroderma fibroblasts. J Immunol. 2004;172:7123–7135.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15153536</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Song K, Wang H, Krebs TL, Danielpour D. Novel roles of Akt and mTOR in suppressing TGF-beta/ALK5-mediated Smad3 activation. EMBO J. 2006;25:58–69.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1356360</ArticleId>
            <ArticleId IdType="pubmed">16362038</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Conery AR, Cao Y, Thompson EA, Townsend CM, Jr, Ko TC, Luo K. Akt interacts directly with Smad3 to regulate the sensitivity to TGF-beta induced apoptosis. Nat Cell Biol. 2004;6:366–372.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15104092</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Remy I, Montmarquette A, Michnick SW. PKB/Akt modulates TGF-beta signalling through a direct interaction with Smad3. Nat Cell Biol. 2004;6:358–365.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15048128</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ghosh-Choudhury N, Abboud SL, Nishimura R, Celeste A, Mahimainathan L, Choudhury GG. Requirement of BMP-2-induced phosphatidylinositol 3-kinase and Akt serine/threonine kinase in osteoblast differentiation and Smad-dependent BMP-2 gene transcription. J Biol Chem. 2002;277:33361–33368.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12084724</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Seoane J, Le HV, Shen L, Anderson SA, Massague J. Integration of Smad and forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferation. Cell. 2004;117:211–223.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15084259</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Atfi A, Abecassis L, Bourgeade MF. Bcr-Abl activates the AKT/Fox O3 signalling pathway to restrict transforming growth factor-beta-mediated cytostatic signals. EMBO Rep. 2005;6:985–991.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1369182</ArticleId>
            <ArticleId IdType="pubmed">16113647</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang SE, Shin I, Wu FY, Friedman DB, Arteaga CL. HER2/Neu (ErbB2) signaling to Rac1-Pak1 is temporally and spatially modulated by transforming growth factor {beta} Cancer Res. 2006;66:9591–9600.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17018616</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bakin AV, Tomlinson AK, Bhowmick NA, Moses HL, Arteaga CL. Phosphatidylinositol 3-kinase function is required for transforming growth factor beta-mediated epithelial to mesenchymal transition and cell migration. J Biol Chem. 2000;275:36803–36810.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10969078</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lamouille S, Derynck R. Cell size and invasion in TGF-{beta} induced epithelial to mesenchymal transition is regulated by activation of the mTOR pathway. J Cell Biol. 2007;178:437–451.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2064840</ArticleId>
            <ArticleId IdType="pubmed">17646396</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhu Y, Culmsee C, Klumpp S, Krieglstein J. Neuroprotection by transforming growth factor-[beta]1 involves activation of nuclear factor-[kappa]B through phosphatidylinositol-3-OH kinase/Akt and mitogen-activated protein kinase-extracellular-signal regulated kinase1, 2 signaling pathways. Neuroscience. 2004;123:897–906.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14751283</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Horowitz JC, Lee DY, Waghray M, et al.  Activation of the pro-survival phosphatidylinositol 3-kinase/AKT pathway by transforming growth factor-{beta}1 in mesenchymal cells is mediated by p38 MAPK-dependent induction of an autocrine growth factor. J Biol Chem. 2004;279:1359–1367.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1360222</ArticleId>
            <ArticleId IdType="pubmed">14576166</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wilkes MC, Mitchell H, Penheiter SG, et al.  Transforming growth factor-{beta} activation of phosphatidylinositol 3-kinase is independent of Smad2 and Smad3 and regulates fibroblast responses via p21-activated kinase-2. Cancer Res. 2005;65:10431–10440.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16288034</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chow JY, Quach KT, Cabrera BL, Cabral JA, Beck SE, Carethers JM. RAS/ERK modulates TGFbeta-regulated PTEN expression in human pancreatic adenocarcinoma cells. Carcinogenesis. 2007;28:2321–2327.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4151289</ArticleId>
            <ArticleId IdType="pubmed">17638924</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vogelmann R, Nguyen-Tat MD, Giehl K, Adler G, Wedlich D, Menke A. TGFbeta-induced downregulation of E-cadherin-based cell-cell adhesion depends on PI3-kinase and PTEN. J Cell Sci. 2005;118:4901–4912.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16219695</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Valderrama-Carvajal H, Cocolakis E, Lacerte A, et al.  Activin/TGF-beta induce apoptosis through Smad-dependent expression of the lipid phosphatase SHIP. Nat Cell Biol. 2002;4:963–969.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12447389</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>He XC, Zhang J, Tong WG, et al.  BMP signaling inhibits intestinal stem cell self-renewal through suppression of Wnt-beta-catenin signaling. Nat Genet. 2004;36:1117–1121.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15378062</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tian Q, He XC, Hood L, Li L. Bridging the BMP and Wnt pathways by PI3 kinase/Akt and 14-3-3zeta. Cell Cycle. 2005;4:215–216.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15655376</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Waite KA, Eng C. BMP2 exposure results in decreased PTEN protein degradation and increased PTEN levels. Hum Mol Genet. 2003;12:679–684.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12620973</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Beck SE, Carethers JM. BMP suppresses PTEN expression via RAS/ERK signaling. Cancer Biol Ther. 2007;6:1313–1317.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4154563</ArticleId>
            <ArticleId IdType="pubmed">18059158</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Haramis A-PG, Begthel H, van den Born M, et al.  De novo crypt formation and juvenile polyposis on BMP inhibition in mouse intestine. Science. 2004;303:1684–1686.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15017003</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cadigan KM, Nusse R. Wnt signaling: a common theme in animal development. Genes Dev. 1997;11:3286–3305.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9407023</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Peifer M, Polakis P. Wnt signaling in oncogenesis and embryogenesis—a look outside the nucleus. Science. 2000;287:1606–1609.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10733430</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Polakis P. The many ways of Wnt in cancer. Curr Opin Genet Dev. 2007;17:45–51.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17208432</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rodriguez-Esteban C, Capdevila J, Kawakami Y, Belmonte JCI. Wnt signaling and PKA control nodal expression and left-right determination in the chick embryo. Development. 2001;128:3189–3195.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11688567</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hoppler S, Moon RT. BMP-2/-4 and Wnt-8 cooperatively pattern the Xenopus mesoderm. Mech Dev. 1998;71:119–129.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9507084</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim J-S, Crooks H, Dracheva T, et al.  Oncogenic {beta}-catenin is required for bone morphogenetic protein 4 expression in human cancer cells. Cancer Res. 2002;62:2744–2748.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12019147</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kosinski C, Li VSW, Chan ASY, et al.  Gene expression patterns of human colon tops and basal crypts and BMP antagonists as intestinal stem cell niche factors. Proc Natl Acad Sci. 2007;104:15418–15423.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2000506</ArticleId>
            <ArticleId IdType="pubmed">17881565</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Abreu JG, Ketpura NI, Reversade B, De Robertis EM. Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-beta. Nat Cell Biol. 2002;4:599–604.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2387275</ArticleId>
            <ArticleId IdType="pubmed">12134160</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Luo Q, Kang Q, Si W, et al.  Connective tissue growth factor (CTGF) is regulated by Wnt and bone morphogenetic proteins signaling in osteoblast differentiation of mesenchymal stem cells. J Biol Chem. 2004;279:55958–55968.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15496414</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Strizzi L, Bianco C, Normanno N, Salomon D. Cripto-1: a multifunctional modulator during embryogenesis and oncogenesis. Oncogene. 2005;24:5731–5741.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16123806</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Crease DJ, Dyson S, Gurdon JB. Cooperation between the activin and Wnt pathways in the spatial control of organizer gene expression. Proc Natl Acad Sci USA. 1998;95:4398–4403.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC22500</ArticleId>
            <ArticleId IdType="pubmed">9539748</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Watabe T, Kim S, Candia A, et al.  Molecular mechanisms of Spemann¢s organizer formation: conserved growth factor synergy between Xenopus and mouse. Genes Dev. 1995;9:3038–3050.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8543150</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Agius E, Oelgeschlager M, Wessely O, Kemp C, De Robertis EM. Endodermal Nodal-related signals and mesoderm induction in Xenopus. Development. 2000;127:1173–1183.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2292107</ArticleId>
            <ArticleId IdType="pubmed">10683171</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xanthos JB, Kofron M, Tao Q, Schaible K, Wylie C, Heasman J. The roles of three signaling pathways in the formation and function of the Spemann organizer. Development. 2002;129:4027–4043.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12163406</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Riese J, Yu X, Munnerlyn A, et al.  LEF-1, a nuclear factor coordinating signaling inputs from wingless and decapentaplegic. Cell. 1997;88:777–787.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9118221</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Niehrs C. Regionally specific induction by the Spemann-Mangold organizer. Nat Rev Genet. 2004;5:425–434.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15153995</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nishita M, Hashimoto MK, Ogata S, et al.  Interaction between Wnt and TGF-beta signalling pathways during formation of Spemann’s organizer. Nature. 2000;403:781–785.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10693808</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Labbé E, Letamendia A, Attisano L. Association of Smads with lymphoid enhancer binding factor 1/T cell-specific factor mediates cooperative signaling by the transforming growth factor-beta and wnt pathways. Proc Natl Acad Sci USA. 2000;97:8358–8363.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC26952</ArticleId>
            <ArticleId IdType="pubmed">10890911</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Laurent MN, Cho KWY. Bone morphogenetic protein antagonism of Spemann’s organizer is independent of Wnt signaling. Dev Biol. 1999;206:157–162.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9986729</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Theil T, Aydin S, Koch S, Grotewold L, Ruther U. Wnt and Bmp signalling cooperatively regulate graded Emx2 expression in the dorsal telencephalon. Development. 2002;129:3045–3054.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12070081</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hussein SM, Duff EK, Sirard C. Smad4 and {beta}-catenin co-activators functionally interact with lymphoid-enhancing factor to regulate graded expression of Msx2. J Biol Chem. 2003;278:48805–48814.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14551209</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Willert J, Epping M, Pollack J, Brown P, Nusse R. A transcriptional response to Wnt protein in human embryonic carcinoma cells. BMC Dev Biol. 2002;2:8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC117803</ArticleId>
            <ArticleId IdType="pubmed">12095419</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lei S, Dubeykovskiy A, Chakladar A, Wojtukiewicz L, Wang TC. The murine gastrin promoter is synergistically activated by transforming growth factor-{beta}/Smad and Wnt signaling pathways. J Biol Chem. 2004;279:42492–42502.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15292219</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Labbé E, Lock L, Letamendia A, et al.  Transcriptional cooperation between the transforming growth factor-{beta} and Wnt pathways in mammary and intestinal tumorigenesis. Cancer Res. 2007;67:75–84.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17210685</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jian H, Shen X, Liu I, Semenov M, He X, Wang XF. Smad3-dependent nuclear translocation of beta-catenin is required for TGF-beta1-induced proliferation of bone marrow-derived adult human mesenchymal stem cells. Genes Dev. 2006;20:666–674.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1413283</ArticleId>
            <ArticleId IdType="pubmed">16543220</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu Z, Tang Y, Qiu T, Cao X, Clemens TL. A Dishevelled-1/Smad1 interaction couples WNT and bone morphogenetic protein signaling pathways in uncommitted bone marrow stromal cells. J Biol Chem. 2006;281:17156–17163.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16621789</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Furuhashi M, Yagi K, Yamamoto H, et al.  Axin facilitates Smad3 activation in the transforming growth factor-β signaling pathway. Mol Cell Biol. 2001;21:5132–5141.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC87238</ArticleId>
            <ArticleId IdType="pubmed">11438668</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Han G, Li AG, Liang Y-Y, et al.  Smad7-induced [beta]-catenin degradation alters epidermal appendage development. Dev Cell. 2006;11:301–312.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16950122</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tang Y, Liu Z, Zhao L, Clemens TL, Cao X. Smad7 stabilizes beta-catenin binding to E-cadherin complex and promotes cell-cell adhesion. J Biol Chem. 2008;283:23956–23963.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2527110</ArticleId>
            <ArticleId IdType="pubmed">18593713</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu W, Rui H, Wang J, et al.  Axin is a scaffold protein in TGF-beta signaling that promotes degradation of Smad7 by Arkadia. EMBO J. 2006;25:1646–1658.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1440825</ArticleId>
            <ArticleId IdType="pubmed">16601693</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Edlund S, Lee SY, Grimsby S, et al.  Interaction between Smad7 and {beta}-catenin: importance for transforming growth factor {beta}-induced apoptosis. Mol Cell Biol. 2005;25:1475–1488.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC548008</ArticleId>
            <ArticleId IdType="pubmed">15684397</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hooper JE, Scott MP. Communicating with Hedgehogs. Nat Rev Mol Cell Biol. 2005;6:306–317.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15803137</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Taipale J, Beachy PA. The Hedgehog and Wnt signalling pathways in cancer. Nature. 2001;411:349–354.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11357142</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lum L, Beachy PA. The Hedgehog response network: sensors, switches, and routers. Science. 2004;304:1755–1759.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15205520</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aza-Blanc P, Kornberg TB. Ci: a complex transducer of the Hedgehog signal. Trends Genet. 1999;15:458–462.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10529809</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hepker J, Blackman RK, Holmgren R. Cubitus interruptus is necessary but not sufficient for direct activation of a wing-specific decapentaplegic enhancer. Development. 1999;126:3669–3677.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10409512</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Muller B, Basler K. The repressor and activator forms of Cubitus interruptus control Hedgehog target genes through common generic gli-binding sites. Development. 2000;127:2999–3007.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10862738</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kawai S, Sugiura T. Characterization of human bone morphogenetic protein (BMP)-4 and -7 gene promoters: activation of BMP promoters by Gli, a sonic hedgehog mediator. Bone. 2001;29:54–61.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11472891</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yoo YA, Kang MH, Kim JS, Oh SC. Sonic hedgehog signaling promotes motility and invasiveness of gastric cancer cells through TGF-beta-mediated activation of the ALK5-Smad 3 pathway. Carcinogenesis. 2008;29:480–490.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18174246</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alvarez J, Sohn P, Zeng X, Doetschman T, Robbins DJ, Serra R. TGFbeta2 mediates the effects of hedgehog on hypertrophic differentiation and PTHrP expression. Development. 2002;129:1913–1924.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11934857</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhao M, Qiao M, Harris SE, Chen D, Oyajobi BO, Mundy GR. The zinc finger transcription factor Gli2 mediates bone morphogenetic protein 2 expression in osteoblasts in response to hedgehog signaling. Mol Cell Biol. 2006;26:6197–6208.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1592805</ArticleId>
            <ArticleId IdType="pubmed">16880529</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hebrok M, Kim SK, Melton DA. Notochord repression of endodermal Sonic hedgehog permits pancreas development. Genes Dev. 1998;12:1705–1713.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC316875</ArticleId>
            <ArticleId IdType="pubmed">9620856</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Du SJ, Devoto SH, Westerfield M, Moon RT. Positive and negative regulation of muscle cell identity by members of the hedgehog and TGF-beta gene families. J Cell Biol. 1997;139:145–156.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2139815</ArticleId>
            <ArticleId IdType="pubmed">9314535</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dennler S, Andre J, Alexaki I, et al.  Induction of sonic hedgehog mediators by transforming growth factor-beta: Smad3-dependent activation of Gli2 and Gli1 expression in vitro and in vivo. Cancer Res. 2007;67:6981–6986.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17638910</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wechsler-Reya RJ, Scott MP. Control of neuronal precursor proliferation in the cerebellum by Sonic Hedgehog. Neuron. 1999;22:103–114.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10027293</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhu G, Mehler MF, Zhao J, Yu Yung S, Kessler JA. Sonic hedgehog and BMP2 exert opposing actions on proliferation and differentiation of embryonic neural progenitor cells. Dev Biol. 1999;215:118–129.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10525354</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rios I, Alvarez-Rodriguez R, Marti E, Pons S. Bmp2 antagonizes sonic hedgehog-mediated proliferation of cerebellar granule neurones through Smad5 signalling. Development. 2004;131:3159–3168.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15197161</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alvarez-Rodriguez R, Barzi M, Berenguer J, Pons S. Bone morphogenetic protein 2 opposes Shh-mediated proliferation in cerebellar granule cells through a TIEG-1-based regulation of Nmyc. J Biol Chem. 2007;282:37170–37180.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17951258</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu F, Massagué J, Ruiz i Altaba A. Carboxy-terminally truncated Gli3 proteins associate with Smads. Nat Genet. 1998;20:325–326.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9843199</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kalderon D. Similarities between the Hedgehog and Wnt signaling pathways. Trends Cell Biol. 2002;12:523–531.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12446114</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lai EC. Notch signaling: control of cell communication and cell fate. Development. 2004;131:965–973.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14973298</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hudson C, Yasuo H. A signalling relay involving Nodal and Delta ligands acts during secondary notochord induction in Ciona embryos. Development. 2006;133:2855–2864.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16835438</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hudson C, Lotito S, Yasuo H. Sequential and combinatorial inputs from Nodal, Delta2/Notch and FGF/MEK/ERK signalling pathways establish a grid-like organisation of distinct cell identities in the ascidian neural plate. Development. 2007;134:3527–3537.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17728350</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zavadil J, Cermak L, Soto-Nieves N, Bottinger EP. Integration of TGF-beta/Smad and Jagged1/Notch signalling in epithelial-to-mesenchymal transition. EMBO J. 2004;23:1155–1165.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC380966</ArticleId>
            <ArticleId IdType="pubmed">14976548</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Niimi H, Pardali K, Vanlandewijck M, Heldin CH, Moustakas A. Notch signaling is necessary for epithelial growth arrest by TGF-{beta} J Cell Biol. 2007;176:695–707.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2064026</ArticleId>
            <ArticleId IdType="pubmed">17325209</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Walsh DW, Roxburgh SA, McGettigan P, et al.  Co-regulation of Gremlin and Notch signalling in diabetic nephropathy. Biochim Biophys Acta. 2008;1782:10–21.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17980714</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Blokzijl A, Dahlqvist C, Reissmann E, et al.  Cross-talk between the Notch and TGF-{beta} signaling pathways mediated by interaction of the Notch intracellular domain with Smad3. J Cell Biol. 2003;163:723–728.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2173673</ArticleId>
            <ArticleId IdType="pubmed">14638857</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Asano N, Watanabe T, Kitani A, Fuss IJ, Strober W. Notch1 signaling and regulatory T cell function. J Immunol. 2008;180:2796–2804.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18292500</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Samon JB, Champhekar A, Minter LM, et al.  Notch1 and TGFbe-ta1 cooperatively regulate Foxp3 expression and the maintenance of peripheral regulatory T cells. Blood. 2008;112:1813–1821.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2518888</ArticleId>
            <ArticleId IdType="pubmed">18550850</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ostroukhova M, Qi Z, Oriss TB, Dixon-McCarthy B, Ray P, Ray A. Treg-mediated immunosuppression involves activation of the Notch-HES1 axis by membrane-bound TGF-beta. J Clin Invest. 2006;116:996–1004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1401482</ArticleId>
            <ArticleId IdType="pubmed">16543950</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dahlqvist C, Blokzijl A, Chapman G, et al.  Functional Notch signaling is required for BMP4-induced inhibition of myogenic differentiation. Development. 2003;130:6089–6099.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14597575</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Takizawa T, Ochiai W, Nakashima K, Taga T. Enhanced gene activation by Notch and BMP signaling cross-talk. Nucleic Acids Res. 2003;31:5723–5731.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC206475</ArticleId>
            <ArticleId IdType="pubmed">14500836</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Itoh F, Itoh S, Goumans MJ, et al.  Synergy and antagonism between Notch and BMP receptor signaling pathways in endothelial cells. EMBO J. 2004;23:541–551.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1271801</ArticleId>
            <ArticleId IdType="pubmed">14739937</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Masuda S, Kumano K, Shimizu K, et al.  Notch1 oncoprotein antagonizes TGF-β/Smad-mediated cell growth suppression via sequestration of coactivator p300. Cancer Sci. 2005;96:274–282.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15904468</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sun Y, Lowther W, Kato K, et al.  Notch4 intracellular domain binding to Smad3 and inhibition of the TGF-beta signaling. Oncogene. 2005;24:5365–5374.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16007227</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Carlson ME, Hsu M, Conboy IM. Imbalance between pSmad3 and Notch induces CDK inhibitors in old muscle stem cells. Nature. 2008;454:528–532.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7761661</ArticleId>
            <ArticleId IdType="pubmed">18552838</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kennard S, Liu H, Lilly B. Transforming growth factor-beta (TGF-1) down-regulates Notch3 in fibroblasts to promote smooth muscle gene expression. J Biol Chem. 2008;283:1324–1333.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17981798</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Grishina IB, Kim SY, Ferrara C, Makarenkova HP, Walden PD. BMP7 inhibits branching morphogenesis in the prostate gland and interferes with Notch signaling. Dev Biol. 2005;288:334–347.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2644052</ArticleId>
            <ArticleId IdType="pubmed">16324690</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Haan C, Kreis S, Margue C, Behrmann I. Jaks and cytokine receptors—an intimate relationship. Biochem Pharmacol. 2006;72:1538–1546.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16750817</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yoshimura A. Signal transduction of inflammatory cytokines and tumor development. Cancer Sci. 2006;97:439–447.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16734720</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hayden MS, Ghosh S. Signaling to NF-kappaB. Genes Dev. 2004;18:2195–2224.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15371334</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Karin M, Cao Y, Greten FR, Li ZW. NF-kappaB in cancer: from innocent bystander to major culprit. Nat Rev Cancer. 2002;2:301–310.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12001991</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li Q, Verma IM. NF-kappaB regulation in the immune system. Nat Rev Immunol. 2002;2:725–734.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12360211</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gorelik L, Flavell RA. Transforming growth factor-beta in T-cell biology. Nat Rev Immunol. 2002;2:46–53.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11905837</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McKarns SC, Schwartz RH, Kaminski NE. Smad3 Is Essential for TGF-{beta}1 to suppress IL-2 production and TCR-induced proliferation, but not IL-2-induced proliferation. J Immunol. 2004;172:4275–4284.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15034041</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nelson BH, Martyak TP, Thompson LJ, Moon JJ, Wang T. Uncoupling of promitogenic and antiapoptotic functions of IL-2 by Smad-dependent TGF-beta signaling. J Immunol. 2003;170:5563–5570.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12759434</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim HP, Kim BG, Letterio J, Leonard WJ. Smad-dependent cooperative regulation of interleukin 2 receptor alpha chain gene expression by T cell receptor and transforming growth factor-beta. J Biol Chem. 2005;280:34042–34047.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16087671</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Burchill MA, Yang J, Vogtenhuber C, Blazar BR, Farrar MA. IL-2 receptor beta-dependent STAT5 activation is required for the development of Foxp3+ regulatory T cells. J Immunol. 2007;178:280–290.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17182565</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Davidson TS, DiPaolo RJ, Andersson J, Shevach EM. Cutting edge: IL-2 is essential for TGF-beta-mediated induction of Foxp3+ T regulatory cells. J Immunol. 2007;178:4022–4026.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17371955</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tone Y, Furuuchi K, Kojima Y, Tykocinski ML, Greene MI, Tone M. Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer. Nat Immunol. 2008;9:194–202.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18157133</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zheng SG, Wang J, Wang P, Gray JD, Horwitz DA. IL-2 Is Essential for TGF-beta to convert naive CD4+CD25− cells to CD25+Foxp3+ regulatory T cells and for expansion of these cells. J Immunol. 2007;178:2018–2027.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17277105</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kang Y, Siegel PM, Shu W, et al.  A multigenic program mediating breast cancer metastasis to bone. Cancer Cell. 2003;3:537–549.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12842083</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kang Y, He W, Tulley S, et al.  Breast cancer bone metastasis mediated by the Smad tumor suppressor pathway. Proc Natl Acad Sci USA. 2005;102:13909–13914.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1236573</ArticleId>
            <ArticleId IdType="pubmed">16172383</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fong Y-C, Maa M-C, Tsai F-J, et al.  Osteoblast-derived TGF-β stimulates IL-8 release through AP-1 and NF-κB in human cancer cells. J Bone Miner Res. 2008;23:961–970.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18435575</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang XL, Topley N, Ito T, Phillips A. Interleukin-6 regulation of transforming growth factor (TGF)-beta receptor compartmentalization and turnover enhances TGF-beta1 signaling. J Biol Chem. 2005;280:12239–12245.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15661740</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Walia B, Wang L, Merlin D, Sitaraman SV. TGF-beta down-regulates IL-6 signaling in intestinal epithelial cells: critical role of SMAD-2. FASEB J. 2003;17:2130–2132.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14500551</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li MO, Sanjabi S, Flavell R. Transforming growth factor-[beta] controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms. Immunity. 2006;25:455–471.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16973386</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Marie JC, Liggitt D, Rudensky AY. Cellular mechanisms of fatal early-onset autoimmunity in mice with the T cell-specific targeting of transforming growth factor-[beta] receptor. Immunity. 2006;25:441–454.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16973387</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ulloa L, Doody J, Massague J. Inhibition of transforming growth factor-[beta]/SMAD signalling by the interferon-[gamma]/STAT pathway. Nature. 1999;397:710–713.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10067896</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ishida Y, Kondo T, Takayasu T, Iwakura Y, Mukaida N. The essential involvement of cross-talk between IFN-{gamma} and TGF-{beta} in the skin wound-healing process. J Immunol. 2004;172:1848–1855.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14734769</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jenkins BJ, Grail D, Nheu T, et al.  Hyperactivation of Stat3 in gp130 mutant mice promotes gastric hyperproliferation and desensitizes TGF-beta signaling. Nat Med. 2005;11:845–852.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16041381</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huang M, Sharma S, Zhu LX, et al.  IL-7 inhibits fibroblast TGF-beta production and signaling in pulmonary fibrosis. J Clin Invest. 2002;109:931–937.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC150933</ArticleId>
            <ArticleId IdType="pubmed">11927620</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Letterio JJ, Roberts AB. Regulation of immune responses by TGF-β. Annu Rev Immunol. 1998;16:137–161.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9597127</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bitzer M, von Gersdorff G, Liang D, et al.  A mechanism of suppression of TGF-beta/SMAD signaling by NF-kappa B/RelA. Genes Dev. 2000;14:187–197.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC316349</ArticleId>
            <ArticleId IdType="pubmed">10652273</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Benus GFJD, Wierenga ATJ, de Gorter DJJ, et al.  Inhibition of the transforming growth factor {beta} (TGF{beta}) pathway by interleukin-1{beta} is mediated through TGF{beta}-activated kinase 1 phosphorylation of SMAD3. Mol Biol Cell. 2005;16:3501–3510.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1182292</ArticleId>
            <ArticleId IdType="pubmed">15917296</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ruiz PA, Shkoda A, Kim SC, Sartor RB, Haller D. IL-10 gene-deficient mice lack TGF-beta/Smad signaling and fail to inhibit proinflammatory gene expression in intestinal epithelial cells after the colonization with colitogenic Enterococcus faecalis. J Immunol. 2005;174:2990–2999.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15728512</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ruiz PA, Shkoda A, Kim SC, Sartor RB, Haller D. IL-10 gene-deficient mice lack TGF-beta/Smad-mediated TLR2 degradation and fail to inhibit proinflammatory gene expression in intestinal epithelial cells under conditions of chronic inflammation. Ann NY Acad Sci. 2006;1072:389–394.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17057220</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kon A, Vindevoghel L, Kouba DJ, Fujimura Y, Uitto J, Mauviel A. Cooperation between SMAD and NF-kappaB in growth factor regulated type VII collagen gene expression. Oncogene. 1999;18:1837–1844.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10086338</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lopez-Rovira T, Chalaux E, Rosa JL, Bartrons R, Ventura F. Interaction and functional cooperation of NF-kappa B with Smads. Transcriptional regulation of the junB promoter. J Biol Chem. 2000;275:28937–28946.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10874048</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nishinakamura R, Matsumoto Y, Matsuda T, et al.  Activation of Stat3 by cytokine receptor gp130 ventralizes Xenopus embryos independent of BMP-4. Dev Biol. 1999;216:481–490.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10642787</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nakashima K, Yanagisawa M, Arakawa H, et al.  Synergistic signaling in fetal brain by STAT3-Smad1 complex bridged by p300. Science. 1999;284:479–482.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10205054</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ying QL, Nichols J, Chambers I, Smith A. BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3. Cell. 2003;115:281–292.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14636556</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Davis BN, Hilyard AC, Lagna G, Hata A. SMAD proteins control DROSHA-mediated microRNA maturation. Nature. 2008;454:56–61.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2653422</ArticleId>
            <ArticleId IdType="pubmed">18548003</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
